Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.448
+0.034 (8.12%)
At close: Mar 9, 2026, 4:00 PM EDT
0.423
-0.024 (-5.45%)
After-hours: Mar 9, 2026, 7:01 PM EDT

Outlook Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 2020 - 2016
Net Income
-102.86-62.42-75.37-58.98-66.05-53.16
Upgrade
Depreciation & Amortization
0.120.120.110.040.20.26
Upgrade
Loss (Gain) on Equity Investments
0.150.140.10.010.050.05
Upgrade
Stock-Based Compensation
6.118.95.395.557.714.89
Upgrade
Other Operating Activities
43.53-4.973.995.653.10.79
Upgrade
Change in Accounts Receivable
-0.11-1.49----
Upgrade
Change in Inventory
-0.35-3.34----
Upgrade
Change in Accounts Payable
-5.431.671.393.081.3-0.2
Upgrade
Change in Other Net Operating Assets
3.059.58-4.411.67-2.98-6.88
Upgrade
Operating Cash Flow
-55.8-51.83-68.79-42.97-56.67-54.25
Upgrade
Long-Term Debt Issued
-33.1-301010
Upgrade
Long-Term Debt Repaid
--36.14-0-10.23-12.32-3.69
Upgrade
Net Debt Issued (Repaid)
-3.04-3.04-019.77-2.326.31
Upgrade
Issuance of Common Stock
61.8248.0360.3330.0262.5149.9
Upgrade
Other Financing Activities
----0.82-0.6-0.01
Upgrade
Financing Cash Flow
58.7844.9860.3348.9759.5956.19
Upgrade
Net Cash Flow
2.97-6.84-8.4662.921.94
Upgrade
Free Cash Flow
-55.8-51.83-68.79-42.97-56.67-54.25
Upgrade
Free Cash Flow Margin
-27127.21%-3666.65%----
Upgrade
Free Cash Flow Per Share
-1.27-1.49-3.71-3.44-5.34-7.11
Upgrade
Cash Interest Paid
--0.481.161.560.05
Upgrade
Levered Free Cash Flow
-34.42-27.15-44.3-24.26-32.53-35.62
Upgrade
Unlevered Free Cash Flow
-34.24-26.97-42.33-22.68-31.6-35.03
Upgrade
Change in Working Capital
-2.846.41-3.024.75-1.68-7.08
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.